209 related articles for article (PubMed ID: 26071779)
21. Mitochondria-targeted plastoquinone antioxidant SkQ1 prevents amyloid-β-induced impairment of long-term potentiation in rat hippocampal slices.
Kapay NA; Popova OV; Isaev NK; Stelmashook EV; Kondratenko RV; Zorov DB; Skrebitsky VG; Skulachev VP
J Alzheimers Dis; 2013; 36(2):377-83. PubMed ID: 23735258
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
Neroev VV; Archipova MM; Bakeeva LE; Fursova AZh; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZhN; Katargina LA; Khoroshilova-Maslova IP; Kilina OV; Kolosova NG; Kopenkin EP; Korshunov SS; Kovaleva NA; Novikova YP; Philippov PP; Pilipenko DI; Robustova OV; Saprunova VB; Senin II; Skulachev MV; Sotnikova LF; Stefanova NA; Tikhomirova NK; Tsapenko IV; Shchipanova AI; Zinovkin RA; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1317-28. PubMed ID: 19120017
[TBL] [Abstract][Full Text] [Related]
23. The glutamate/GABA system in the retina of male rats: effects of aging, neurodegeneration, and supplementation with melatonin and antioxidant SkQ1.
Telegina DV; Antonenko AK; Fursova AZ; Kolosova NG
Biogerontology; 2022 Oct; 23(5):571-585. PubMed ID: 35969289
[TBL] [Abstract][Full Text] [Related]
24. The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy.
Perepechaeva ML; Grishanova AY; Rudnitskaya EA; Kolosova NG
J Ophthalmol; 2014; 2014():530943. PubMed ID: 25132985
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure.
Vays VB; Eldarov CM; Vangely IM; Kolosova NG; Bakeeva LE; Skulachev VP
Aging (Albany NY); 2014 Feb; 6(2):140-8. PubMed ID: 24519884
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1.
Shipounova IN; Svinareva DA; Petrova TV; Lyamzaev KG; Chernyak BV; Drize NI; Skulachev VP
Mech Ageing Dev; 2010 Jun; 131(6):415-21. PubMed ID: 20600239
[TBL] [Abstract][Full Text] [Related]
27. Development of behavioural dysfunctions in accelerated-senescence OXYS rats is associated with early postnatal alterations in brain phosphate metabolism.
Sergeeva S; Bagryanskaya E; Korbolina E; Kolosova N
Exp Gerontol; 2006 Feb; 41(2):141-50. PubMed ID: 16310999
[TBL] [Abstract][Full Text] [Related]
28. Changes in Glial Support of the Hippocampus during the Development of an Alzheimer's Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1.
Rudnitskaya EA; Burnyasheva AO; Kozlova TA; Peunov DA; Kolosova NG; Stefanova NA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163053
[TBL] [Abstract][Full Text] [Related]
29. [The senescence-accelerated oxys rats--a genetic model of premature aging and age-dependent degenerative diseases].
Kolosova NG; Stefanova NA; Korbolina EE; Fursova AZh; Kozhevnikova OS
Adv Gerontol; 2014; 27(2):336-40. PubMed ID: 25306668
[TBL] [Abstract][Full Text] [Related]
30. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects.
Skulachev VP
Biochemistry (Mosc); 2007 Dec; 72(12):1385-96. PubMed ID: 18205623
[TBL] [Abstract][Full Text] [Related]
31. Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland.
Bakeeva LE; Eldarov CM; Vangely IM; Kolosova NG; Vays VB
Oncotarget; 2016 Dec; 7(49):80208-80222. PubMed ID: 27852065
[TBL] [Abstract][Full Text] [Related]
32. Effects of mitochondria-targeted plastoquinone derivative antioxidant (SkQ1) on demography of free-breeding Campbell dwarf hamsters (Phodopus campbelli) kept in outdoor conditions. reproduction and lifespan: explanation in the framework of ultimate loads.
Rogovin KA; Khrushcheva AM; Shekarova ON; Ushakova MV; Manskikh VN; Sokolova OV; Vasilieva NY
Biochemistry (Mosc); 2014 Oct; 79(10):1117-29. PubMed ID: 25519070
[TBL] [Abstract][Full Text] [Related]
33. Effect of SkQ1 eye drops on the rat lens metabolomic composition and the chaperone activity of α-crystallin.
Yanshole LV; Yanshole VV; Snytnikova OA; Fursova AZh; Kolosova NG; Tsentalovich YP; Sagdeev RZ
Dokl Biochem Biophys; 2015; 464():341-5. PubMed ID: 26518564
[TBL] [Abstract][Full Text] [Related]
34. Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1.
Shabalina IG; Vyssokikh MY; Gibanova N; Csikasz RI; Edgar D; Hallden-Waldemarson A; Rozhdestvenskaya Z; Bakeeva LE; Vays VB; Pustovidko AV; Skulachev MV; Cannon B; Skulachev VP; Nedergaard J
Aging (Albany NY); 2017 Feb; 9(2):315-339. PubMed ID: 28209927
[TBL] [Abstract][Full Text] [Related]
35. Brain proteoglycans in postnatal development and during behavior decline in senescence-accelerated OXYS rats.
Rykova VI; Leberfarb EY; Stefanova NA; Shevelev OB; Dymshits GM; Kolosova NG
Adv Gerontol; 2011; 24(2):234-43. PubMed ID: 21957580
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.
Agapova LS; Chernyak BV; Domnina LV; Dugina VB; Efimenko AY; Fetisova EK; Ivanova OY; Kalinina NI; Khromova NV; Kopnin BP; Kopnin PB; Korotetskaya MV; Lichinitser MR; Lukashev AL; Pletjushkina OY; Popova EN; Skulachev MV; Shagieva GS; Stepanova EV; Titova EV; Tkachuk VA; Vasiliev JM; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1300-16. PubMed ID: 19120016
[TBL] [Abstract][Full Text] [Related]
37. Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.
Stefanova NA; Kozhevnikova OS; Vitovtov AO; Maksimova KY; Logvinov SV; Rudnitskaya EA; Korbolina EE; Muraleva NA; Kolosova NG
Cell Cycle; 2014; 13(6):898-909. PubMed ID: 24552807
[TBL] [Abstract][Full Text] [Related]
38. [MORPHOLOGICAL CHARACTERIZATION OF OXYS AND WISTAR RAT HIPPOCAMPUS IN THE AGING PROCESS].
Maksimova KY; Logvinov SV; Stefanova NA
Morfologiia; 2015; 147(3):11-6. PubMed ID: 26390540
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke).
Bakeeva LE; Barskov IV; Egorov MV; Isaev NK; Kapelko VI; Kazachenko AV; Kirpatovsky VI; Kozlovsky SV; Lakomkin VL; Levina SB; Pisarenko OI; Plotnikov EY; Saprunova VB; Serebryakova LI; Skulachev MV; Stelmashook EV; Studneva IM; Tskitishvili OV; Vasilyeva AK; Victorov IV; Zorov DB; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1288-99. PubMed ID: 19120015
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.
Tikhonova MA; Ho SC; Akopyan AA; Kolosova NG; Weng JC; Meng WY; Lin CL; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2017 Jul; 330():8-16. PubMed ID: 28487222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
